Kevin A. Schulman, MD, MBA, is a professor of medicine at Duke University who’s recent work has received national recognition. In an article published in The Journal of the American Medical Association (JAMA) he and others proposed new solutions to generic drug market volatility, and his collaborative work in The New England Journal of Medicine (NEJM) focused on the impact of specialty pharmaceuticals on insurance premiums. The NEJM article was also featured in a recent The New York Times story entitled “I Am Paying for Your Expensive Medicine”. Congratulations Dr. Schulman! Hear more about this exciting news below in our first ever spotlight video!